Cas:79-72-1 5-Amino-2-methyl-N-phenylbenzenesulfonamide manufacturer & supplier

We serve Chemical Name:5-Amino-2-methyl-N-phenylbenzenesulfonamide CAS:79-72-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-Amino-2-methyl-N-phenylbenzenesulfonamide

Chemical Name:5-Amino-2-methyl-N-phenylbenzenesulfonamide
CAS.NO:79-72-1
Synonyms:5-Amino-2-toluenesulfonanilide;5-amino-2-methyl-N-phenyl-benzenesulfonamide;Benzenesulfonamide, 5-amino-2-methyl-N-phenyl-;5-Amino-o-toluenesulfonanilide;4-Aminotoluene-2-sulphonanilide;EINECS 201-221-7;4-amino-toluene-2-sulfonic acid anilide;o-Toluenesulfonanilide,5-amino;5-Amino-2-methyl-N-phenylbenzenesulfonamide;MFCD00025372;4-AMINOTOLUENE-2-SULFONANILIDE;5-Amino-ortho-toluenesulfonanilide;4-Amino-toluol-2-sulfonsaeure-anilid;Benzenesulfonamide,5-amino-2-methyl-N-phenyl
Molecular Formula:C13H14N2O2S
Molecular Weight:262.328
HS Code:2935009090

Physical and Chemical Properties:
Melting point:42-50 °C(lit.)
Boiling point:467.3±55.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.653
PSA:80.57000
Exact Mass:262.077606
LogP:1.51

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5-Amino-2-toluenesulfonanilide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzenesulfonamide,5-amino-2-methyl-N-phenyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzenesulfonamide, 5-amino-2-methyl-N-phenyl- Use and application,EINECS 201-221-7 technical grade,usp/ep/jp grade.


Related News: It was not clear which inquiry – the company’s or the government’s – was launched first and to what extent the subjects coincide. However, as Reuters reported last month, based on three sources familiar with the matter, the Justice Department’s investigation into Lilly includes a review of alleged manufacturing irregularities and records-tampering. 5-Amino-2-methyl-N-phenylbenzenesulfonamide manufacturer The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes. 5-Amino-2-methyl-N-phenylbenzenesulfonamide supplier The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes. 5-Amino-2-methyl-N-phenylbenzenesulfonamide vendor It was not clear which inquiry – the company’s or the government’s – was launched first and to what extent the subjects coincide. However, as Reuters reported last month, based on three sources familiar with the matter, the Justice Department’s investigation into Lilly includes a review of alleged manufacturing irregularities and records-tampering. 5-Amino-2-methyl-N-phenylbenzenesulfonamide factory Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management, Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.